MCMichael David Cobler‐Lichter

Michael David Cobler‐Lichter

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michael David Cobler‐Lichter has a total of 112 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Embolization versus Nephrectomy in Hemodynamically Stable Patients with American Association for the Surgery of Trauma Grade III–V Blunt Kidney Injuries: Association with Lower Rates of Acute Kidney Injury and In-Hospital Mortality

    by Waseem Wahood, Muhammad U. Shahid, Michael Cobler-Lichter, Christopher F. O’NEil, Alexis K. Jones, Jonathan P. Meizoso, Brianna L. Collie, Talia Arcieri, Kenneth G. Proctor, Joyce I. Kaufman, et al.

  • Development and External Validation of a Machine Learning–Based Simplified Injury Severity Score for Improved Trauma Mortality Prediction

    by Michael D Cobler-Lichter, Ana M Reyes, Jessica M Delamater, Talia R Arcieri, Jonathan P Meizoso, Carl I Schulman, Brandon M Parker, Kenneth G Proctor, Tyler J Loftus, Nicholas Namias

    Background: Trauma quality improvement requires timely, accurate injury severity quantification. Injury Severity Score (ISS), the standard measure, is typically calculated after discharge, requires manual abstraction of Abbreviated Injury Scale scores, and excludes physiologic information. We hypothesized that a machine learning (ML)-based severity score using early clinical variables would improve mortality prediction, particularly in severely injured patients. Study Design: ML model development used 4,521,790 patients from the American College of Surgeons Trauma Quality Improvement Program (2017–2021), with external validation in 12,858 patients from an urban Level 1 trauma center registry (2022–2025). In-hospital mortality was the primary endpoint. Multiple model architectures were compared, the best-performing pipeline was locked a priori, and discrimination versus ISS and Trauma and Injury Severity Score (TRISS) was assessed by paired bootstrap testing. Results: In external validation, the gradient-boosted decision tree-based ML-ISS demonstrated greater discrimination than ISS (AUROC 0.975 [95% CI 0.969-0.980] vs 0.871 [95% CI 0.852-0.888], p<0.0001) and similar discrimination to TRISS (0.973 [95% CI 0.966-0.979], p=0.239). Among patients with ISS≥30, ML-ISS outperformed both ISS (AUROC 0.913 [95% CI 0.893-0.933] vs 0.637 [95% CI 0.595-0.676], p<0.0001) and TRISS (0.897 [95% CI 0.873-0.919], p=0.021). Conclusions: ML-ISS improved mortality discrimination over ISS and, among severely injured patients, outperformed both ISS and TRISS. These externally validated findings support prospective multicenter evaluation of ML-ISS for trauma benchmarking and quality-improvement workflows.

  • Who Is at Greatest Risk for Financial Toxicity? A Nationwide Survey of Burn Survivors

    by Ana M Reyes, Stephen Q Conrad, Walter A Ramsey, Christopher F O’NEil, Michael D Cobler-Lichter, Jessica M Delamater, Talia R Arcieri, Mary Ishii, Shevonne S Satahoo, Joyce I Kaufman, et al.

    Financial toxicity is increasingly recognized as an important determinant of recovery, yet limited data exist regarding its prevalence among burn survivors. We evaluated financial toxicity in a nationwide cohort of burn survivors and sought to identify predictors of increased risk. We hypothesized that financial toxicity would be more common among survivors with larger burns. An online survey was distributed to burn survivors recruited through the Phoenix Society for Burn Survivors in 2023. The primary outcome was any financial toxicity, defined as survivors identifying “financial assistance” or “impact of injury on income” among their greatest unmet needs. Multivariable logistic regression determined independent predictors. Qualitative responses were analyzed for financial-related themes. Among 178 respondents, 31.5% reported financial toxicity. Financial toxicity was most common among survivors aged 18-44 years (41.8%) and those within 3 years of injury (50.0%). On multivariable analysis, younger age (aOR 3.37, 95% CI 1.21-9.40), larger burns (21%-40% TBSA: aOR 4.76, 95% CI 1.34-16.83; >40% TBSA: aOR 7.85, 95% CI 2.21-27.92), and shorter time since injury (<1 year: aOR 4.72, 95% CI 1.38-16.19; 1-3 years: aOR 5.98, 95% CI 1.98-18.07) were independently associated with increased odds. Qualitative responses highlighted ongoing challenges related to insurance coverage and access to reconstructive and supportive therapies. In conclusion, financial toxicity is an important yet underrecognized component of burn survivorship, particularly among younger survivors, those with larger burns, and those earlier in recovery. Additional efforts are needed to better understand its long-term impact and identify effective interventions to mitigate financial hardship after burn injury.

  • Military-Civilian Partnership Surgeon Performance Analysis by a Novel Current Procedural Terminology to Individual Critical Task List Map

    by Talia R Arcieri, Michael D Cobler-Lichter, Jessica M Delamater, Ana M Reyes, Callie L Spohn, Nicholas Namias, Vincente S Nelson, Mark D Buzzelli, Kenneth G Proctor, Carl I Schulman, et al.

    Introduction: Maintaining clinical readiness of military surgeons is essential for optimal combat casualty care, yet limited exposure to high-acuity trauma in military treatment facilities (MTFs) contributes to skill degradation during peacetime. Military-civilian partnerships (MCPs) have emerged as a key strategy to address this gap by embedding military surgeons within high volume civilian trauma centers. However, objectively measuring whether clinical experience translates into readiness remains challenging because of the disconnect between civilian billing-based documentation using current procedural terminology (CPT) codes and military readiness frameworks such as the United States (U.S.) Army General Surgeon Individual Critical Task List (ICTL). This study aimed to develop a CPT-to-ICTL mapping framework to quantify U.S. Army surgeon readiness within a long established MCP. Materials and Methods: A retrospective observational study was conducted at a single urban academic Level I trauma center MCP from May 2020 through September 2024. CPT codes from the CPT 2024 Professional Edition were categorized as definitively or potentially satisfying an individual critical task (ICT), with the latter requiring operative or procedural documentation review for confirmation. Billing logs for 2 MCP embedded U.S. Army surgeons (Surgeons A and B) were analyzed, excluding non-procedural and non-critical care codes. During the study period, Surgeon A contributed 48 months of clinical time while Surgeon B contributed 42 months because of periods of deployment and offsite military training. CPT codes were grouped by encounter, mapped to ICTs, and counted once per encounter to avoid duplication. Descriptive statistics were used to summarize ICT frequency. The study was approved by the local Institutional Review Board with a waiver of informed consent. Results: The CPT-to-ICTL mapping framework identified 1,239 CPT codes corresponding to 1,772 CPT-to-ICT associations. Open abdominal and thoracic procedures accounted for the largest proportion of mapped codes. Surgeon A and Surgeon B completed 2,020 and 1,358 ICTs, respectively. The most frequently performed ICT was the Focused Assessment with Sonography in Trauma (FAST) examination, with laparotomy as the most common operative task. Additional commonly performed ICTs included tube thoracostomy, trauma resuscitation, and critical care management. Conclusions: This novel approach to quantifying military surgical readiness links administrative billing data to readiness-defined tasks. The findings support MCPs as effective environments for generating exposure to combat-relevant clinical activities while highlighting the feasibility of using CPT-based frameworks for objective readiness assessment. This framework has important implications for readiness reporting, program evaluation, and policy development within the Military Health System. Future work should validate this approach across diverse settings, incorporate non-procedural aspects of care, and align readiness metrics with clinical outcomes and deployment performance.

  • High-ratio plasma resuscitation decreases mortality in moderate traumatic brain injury

    by Talia R. Arcieri, Michael D. Md Cobler-Lichter, Jessica M. Delamater, Ana M. Reyes, Joshua P. Kronenfeld, Nicholas Md Namias, Kenneth G. Proctor, Jonathan P. Md Meizoso, Enrique Ginzburg, Fl Miami

    BACKGROUND: Traumatic brain injury (TBI) is a leading cause of trauma-related mortality. While high ratios of fresh frozen plasma (FFP):red blood cells (RBC) improve survival in hemorrhagic shock, the role of FFP in polytrauma patients with TBI not requiring massive transfusion is unclear. We hypothesized that higher FFP ratios would be associated with improved early and late survival across TBI severities. METHODS: Adult trauma patients (age 18 or older) with suspected TBI (head AIS ≥1) who received ≥1 unit of blood product from 2020 to 2021 were identified in the American College of Surgeon’s Trauma Quality Improvement Project database. Burns, interfacility transfers, and massive transfusion (≥5 RBC-containing units within 4 hours) were excluded. Patients were stratified by head AIS (mild 1–2, moderate 3–4, and severe 5–6). FFP ratio was calculated as FFP:total transfused blood products, and patients were categorized as receiving no FFP, low FFP, or high FFP, with the median of non-zero FFP ratios used to divide low from high. Multivariable logistic regression was performed to assess the association between FFP ratios and 6-hour and 30-day mortality. Subgroup analyses of isolated TBI patients and sensitivity analyses excluding whole blood recipients were performed. RESULTS: In 23,362 patients, 40.1% had mild TBI, 35.9% moderate, and 24.0% severe. Overall, 6-hour and 30-day mortality rates were 12.6% and 32.4%, respectively. High FFP ratios were associated with lower 6-hour mortality in moderate and severe TBI, with a sustained 30-day survival benefit only in moderate TBI. Low FFP ratios decreased only early mortality in moderate and severe TBI. Subgroup and sensitivity analyses demonstrated the greatest survival benefit in moderate TBI. CONCLUSION: The association between FFP and mortality varies across TBI severity groups and proportions of FFP given in initial resuscitation. These findings suggest that moderate TBI patients may benefit most from high-ratio FFP resuscitation. ( J Trauma Acute Care Surg . 2026;00: 00–00. Copyright © 2026 Wolters Kluwer Health, Inc. All rights reserved.) LEVEL OF EVIDENCE: Therapeutic/Care Management; Level III.

  • Surgical Stabilization of Fractures in Combat Trauma: External Fixation During the Global War on Terror

    by Michael D Cobler-Lichter, Talia R Arcieri, Jessica M Delamater, Ana M Reyes, Jonathan D Stallings, Vincente S Nelson, Nicholas Namias, Kirby R Gross, Shawn E Boomsma, Mark D Buzzelli, et al.

    Introduction: Role 2 (R2) U.S. military treatment facilities (MTFs) provide forward damage control resuscitation and surgery. There are many configurations of R2 surgical teams, but each service defines external fixation (EF) as a requisite skill. To inform planning of potential future conflicts, this study describes EF utilization in recent past conflicts. Materials and Methods: The Department of Defense Trauma Registry (DoDTR) was retrospectively reviewed from 2003 to 2023. All combat casualties who underwent EF at U.S. MTFs were included. The primary outcome was the MTF level at which EF was performed. Secondary outcomes included the anatomic site of EF and population receiving EFs. Trends in these outcomes were evaluated across time and military operation. Results: Six thousand one hundred eleven patients received 9,310 EFs; 2,600 were U.S. casualties, 1,630 foreign civilian, 275 North Atlantic Treaty Organization (NATO) military, and 1,605 non-NATO military. 19.5% of EFs were placed at R2, 67.6% at Role 3 (R3), 4.9% at Role 4 (R4), and 8.0% at R4-Continental US (R4C) MTFs. 78.0% of patients undergoing their first EF at R3 bypassed the R2. 67.5% of EFs were on the lower extremity and 19.4% were on the upper extremity. At both R2 and R3, the lower extremity was the predominant EF site (69.6% and 67.3% respectively). External pelvic fixation was rarely performed (0.3% and 0.1%). Conclusions: These results offer valuable insight into modern logistical concerns in the delivery of forward surgical care. First and foremost, it underscores the importance of maintaining EF capability in expeditionary surgical teams, especially at lower echelons of care. Given the increasing prevalence of EF at R2s and the logistical challenges of evacuation in future conflicts, consideration should be given to both sustaining orthopedic-trained surgeons in theater and ensuring all general surgeons have robust orthopedic capabilities.


  • Sex-based differences in post-injury behavioral health readmissions among adolescents hospitalized for firearm injuries

    by Ana M. Reyes, Blair Chang, Nicholas J. Iglesias, Talia R. Arcieri, Jessica M. Delamater, Michael D. Cobler-Lichter, Julie Y. Valenzuela, Joshua P. Parreco, Eduardo A. Perez, Juan E. Sola, et al.


  • Machine Learning Models to Predict Withdrawal of Life-Sustaining Therapy in Patients With Severe Traumatic Brain Injury

    by Michael Cobler-Lichter, Jessica M. Delamater, Fernanda J.P. Teixeira, Ana M. Reyes, Talia R. Arcieri, Brian Manolovitz, John A. McKeown, Tulay Koru-Sengul, Jonathan Jagid, Joacir Graciolli Cordeiro, et al.

  • Open Access

    Cryo on call: Pathogen-reduced cryoprecipitated fibrinogen complex is associated with improved fibrinogen supplementation in hemorrhaging trauma patients

    by Michael D. Cobler-Lichter, Talia R. Arcieri, Baylee M. Brochu, Jessica M. Delamater, Ana M. Reyes, YanYun Wu, Nicholas Namias, Kenneth G. Proctor, Jonathan P. Meizoso, Roman Dudaryk

    INTRODUCTION: Fibrinogen supplementation (FS) is commonly achieved with cryoprecipitate, although the required on-demand thawing often results in delayed FS. Pathogen-reduced cryoprecipitated fibrinogen complex (INTERCEPT fibrinogen complex [IFC]), a novel product, can be stored thawed for up to 5 days, allowing for immediate availability. We hypothesized that IFC implementation at our level 1 trauma center would be associated with increased likelihood of FS, decreased mortality, and transfusion requirement (TR). METHODS: This was a retrospective review from a single level 1 trauma center from 2022 to 2024, spanning 1 year pre- and post-IFC implementation. Adults who received >900 mL of red blood cells and/or whole blood (WB) within 1 hour were included to identify patients who reached critical administration threshold, indicating significant hemorrhage, without excluding those being resuscitated primarily with WB. Multiple logistic regression assessed the independent effect of IFC implementation on the likelihood of FS and 24-hour mortality. Linear regression modeled TR. RESULTS: In 294 included patients, 24.1% received FS (21.4% pre-IFC, 26.6% post-IFC, p = 0.299). Post-IFC patients tended to be older (44 vs. 39, p = 0.011) and had blunt trauma more often (67.5% vs. 53.6%, p = 0.009), lower shock index (0.87 vs. 0.99, p = 0.004), higher rates of WB use (72.1% vs. 37.9%, p < 0.001), and lower 4-hour TR (2.0 vs. 2.4 L, p = 0.027) but similar ISS, GCS, base deficit, and hematocrit. After controlling for these differences, IFC implementation was associated with increased likelihood of FS (adjusted odds ratio, 2.45; 95% confidence interval, 1.05–5.74), but not with 24-hour mortality or 4-hour TR. Although not statistically significant, there was a trend to earlier FS (median, 67 vs. 42 minutes; p = 0.070; rates of FS within 60 minutes, 40.0% vs. 63.4%; p = 0.051). CONCLUSION: INTERCEPT fibrinogen complex implementation at our level 1 trauma center was independently associated with FS, but not mortality or TR. Hemorrhaging patients with hypofibrinogenemia, a time-sensitive predictor of mortality in trauma, may benefit from IFC. LEVEL OF EVIDENCE: Prognostic and Epidemiological; Level III.


  • Potential and pitfalls: accuracy versus adequacy of ChatGPT’s performance on surgery shelf examination

    by Baylee Brochu, Michael D. Cobler-Lichter, Talia R. Arcieri, Nikita M. Shah, Jessica M. Delamater, Ana M. Reyes, Matthew S. Sussman, Edward B. Lineen, Laurence R. Sands, Vanessa W. Hui, et al.